<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Bryostatin 1, a macrocyclic <z:chebi fb="0" ids="25000">lactone</z:chebi> isolated from the marine bryozoan Bugula neritina, has demonstrated both <z:chebi fb="0" ids="35610">antineoplastic</z:chebi> activity against the murine P388 <z:hpo ids='HP_0001909'>leukemia</z:hpo> line in vivo and stimulatory activity against mouse and human hematopoietic progenitors </plain></SENT>
<SENT sid="1" pm="."><plain>We studied the effects of bryostatin 1 on the growth of human <z:hpo ids='HP_0001909'>leukemias</z:hpo> in vitro </plain></SENT>
<SENT sid="2" pm="."><plain>Bryostatin 1 inhibited 1 to 4 logs of clonogenic <z:hpo ids='HP_0001909'>leukemia</z:hpo> cell growth from three of four <z:hpo ids='HP_0001909'>leukemia</z:hpo> cell lines </plain></SENT>
<SENT sid="3" pm="."><plain>Bryostatin 1 also inhibited, by at least 1 log, the proliferation of clonogenic <z:hpo ids='HP_0011009'>acute</z:hpo> nonlymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (ANLL) cells from 10 to 12 patients with newly diagnosed or relapsed ANLL </plain></SENT>
<SENT sid="4" pm="."><plain>Maximal inhibition of leukemic growth occurred at 10(-9) to 10(-7) mol/L bryostatin 1 </plain></SENT>
<SENT sid="5" pm="."><plain>Interestingly, bryostatin 1 also inhibited the growth of hematopoietic progenitors from eight patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0001909'>Leukemia</z:hpo> cells exposed to bryostatin 1 for up to 96 hours and then washed, demonstrated no substantial inhibition of clonogenic growth, indicating that the anti-leukemic effect of bryostatin 1 is <z:chebi fb="0" ids="35610">cytostatic</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>The <z:chebi fb="0" ids="37532">phorbol ester</z:chebi> 12-0-tetradecanoylphorbol-13-<z:chebi fb="49" ids="30089,47622">acetate</z:chebi> (<z:chebi fb="6" ids="15702,53394">TPA</z:chebi>) produced more potent inhibition of clonogenic <z:hpo ids='HP_0001909'>leukemia</z:hpo> growth, and this inhibition was blocked by bryostatin 1 </plain></SENT>
<SENT sid="8" pm="."><plain>Thus, the anti-leukemic activity of bryostatin 1 may be mediated through activation of protein kinase C </plain></SENT>
<SENT sid="9" pm="."><plain>Bryostatin 1 inhibits clonogenic <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells at concentrations that stimulate <z:mpath ids='MPATH_458'>normal</z:mpath> hematopoietic progenitors </plain></SENT>
<SENT sid="10" pm="."><plain>The differential effects of bryostatin 1 on <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:mp ids='MP_0002123'>abnormal hematopoiesis</z:mp> suggest that bryostatin 1 may have value in the treatment of <z:hpo ids='HP_0001909'>leukemias</z:hpo> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>